Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genelux Corp (GNLX)

Genelux Corp (GNLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference

WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO...

GNLX : 4.37 (-5.82%)
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

-- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data from OnPrime Phase 3 ovarian cancer registrational trial expected in the second half of 2026...

GNLX : 4.37 (-5.82%)
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick , President, CEO...

GNLX : 4.37 (-5.82%)
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter...

GNLX : 4.37 (-5.82%)
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

GNLX : 4.37 (-5.82%)
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

GNLX : 4.37 (-5.82%)
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

GNLX : 4.37 (-5.82%)
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GNLX : 4.37 (-5.82%)
Employment Reports to Roll Out Next Friday in Both Countries

Employment Reports to Roll Out Next Friday in Both Countries U.S. Monday Featured Earnings ...

PVH : 74.84 (-4.65%)
LIEN : 10.69 (+0.09%)
SPWH : 1.6900 (+2.42%)
CAG : 17.14 (+0.18%)
PRGS : 43.88 (+0.78%)
PENG : 22.11 (+2.46%)
LW : 59.53 (-0.28%)
UNF : 179.65 (-0.20%)
BYRN : 18.99 (-3.46%)
LEVI : 21.64 (unch)
AYI : 373.41 (+0.31%)
NCNO : 24.58 (+5.09%)
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

GNLX : 4.37 (-5.82%)

Barchart Exclusives

After a Red-Hot Rally on S&P 500 Inclusion, Carvana Stock Needs a ‘Cool’ Option Collar. How to Trade CVNA Here.
Here’s how you can keep chasing the upside in Carvana while minimizing your downside risk. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar